Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call on 11th August 2021 at 11 AM09-08-2021
09-08-2021
Nath Bio-Genes (India) Ltd - 537291 - Notice Of Annual General Meeting And Annual Report 2020-21
Notice of Annual General Meeting and Annual Report 2020-2105-08-2021
Nath Bio-Genes (India) Ltd - 537291 - Reg. 34 (1) Annual Report
Annual Report for 2020-2105-08-2021
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for To Consider And Approve Unaudited Quarterly Financial Results For The Quarter Ended 30Th June 2021
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve unaudited quarterly financial results for the quarter ended 30th June 202102-08-2021
Nath Bio-Genes (India) Ltd - 537291 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirement)Regulation 2015.
Disclosure of Related Party Transaction under regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirement)Regulation 2015.22-07-2021
Nath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended June 30, 2021
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here14-07-2021
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nath Royal Ltd13-07-2021
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.09-07-2021
Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr Dhiraj RathiDesignation :- Company Secretary and Compliance Officer09-07-2021
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference Call held on 25th June 2021.01-07-2021